Publication Information

{'id': 'https://openalex.org/W4387393286', 'doi': None, 'title': '[Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine(A+AVD)Therapy for Classical Hodgkin Lymphoma- A Single-Institution Experience].', 'display_name': '[Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine(A+AVD)Therapy for Classical Hodgkin Lymphoma- A Single-Institution Experience].', 'publication_year': 2023, 'publication_date': '2023-09-01', 'ids': {'openalex': 'https://openalex.org/W4387393286', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/37800293'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/37800293', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5025440917', 'display_name': 'Mirei Kobayashi', 'orcid': 'https://orcid.org/0000-0001-7340-5277'}, 'institutions': [{'id': 'https://openalex.org/I4210099235', 'display_name': 'Kisarazu Hospital', 'ror': 'https://ror.org/011nerd04', 'country_code': 'JP', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210099235']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Mirei Kobayashi', 'raw_affiliation_strings': ['Blood Disorders Center, Aiiku Hospital.'], 'affiliations': [{'raw_affiliation_string': 'Blood Disorders Center, Aiiku Hospital.', 'institution_ids': ['https://openalex.org/I4210099235']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039515152', 'display_name': 'Emi Yokoyama', 'orcid': 'https://orcid.org/0000-0001-8754-3806'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Emi Yokoyama', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011751372', 'display_name': 'Koh Izumiyama', 'orcid': 'https://orcid.org/0000-0002-0762-6255'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Koh Izumiyama', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053000890', 'display_name': 'Akio Mori', 'orcid': 'https://orcid.org/0000-0002-2064-2145'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Akio Mori', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100714642', 'display_name': 'Makoto Saito', 'orcid': 'https://orcid.org/0000-0002-2683-9475'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Makoto Saito', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109310740', 'display_name': 'Masanobu Morioka', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Masanobu Morioka', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5064182775', 'display_name': 'Takeshi Kondo', 'orcid': 'https://orcid.org/0000-0001-7455-5824'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Takeshi Kondo', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 68}, 'biblio': {'volume': '50', 'issue': '9', 'first_page': '979', 'last_page': '983'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.9874, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Colorectal Cancer Treatments and Studies', 'score': 0.9479, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dacarbazine', 'display_name': 'Dacarbazine', 'score': 0.9689222}, {'id': 'https://openalex.org/keywords/abvd', 'display_name': 'ABVD', 'score': 0.9525078}, {'id': 'https://openalex.org/keywords/brentuximab-vedotin', 'display_name': 'Brentuximab vedotin', 'score': 0.8963613}], 'concepts': [{'id': 'https://openalex.org/C2780964509', 'wikidata': 'https://www.wikidata.org/wiki/Q416975', 'display_name': 'Dacarbazine', 'level': 3, 'score': 0.9689222}, {'id': 'https://openalex.org/C2776305933', 'wikidata': 'https://www.wikidata.org/wiki/Q287631', 'display_name': 'ABVD', 'level': 5, 'score': 0.9525078}, {'id': 'https://openalex.org/C2777132456', 'wikidata': 'https://www.wikidata.org/wiki/Q282629', 'display_name': 'Vinblastine', 'level': 3, 'score': 0.92074907}, {'id': 'https://openalex.org/C2778191690', 'wikidata': 'https://www.wikidata.org/wiki/Q422324', 'display_name': 'Brentuximab vedotin', 'level': 4, 'score': 0.8963613}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.79175925}, {'id': 'https://openalex.org/C2776232574', 'wikidata': 'https://www.wikidata.org/wiki/Q415571', 'display_name': 'Bleomycin', 'level': 3, 'score': 0.6921616}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.59643036}, {'id': 'https://openalex.org/C2781303535', 'wikidata': 'https://www.wikidata.org/wiki/Q18936', 'display_name': 'Doxorubicin', 'level': 3, 'score': 0.48577836}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.47976217}, {'id': 'https://openalex.org/C146357865', 'wikidata': 'https://www.wikidata.org/wiki/Q1123245', 'display_name': 'Stage (stratigraphy)', 'level': 2, 'score': 0.4541901}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.37960947}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.35845459}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.35265473}, {'id': 'https://openalex.org/C2779429289', 'wikidata': 'https://www.wikidata.org/wiki/Q408977', 'display_name': 'Vincristine', 'level': 4, 'score': 0.29723424}, {'id': 'https://openalex.org/C2992779791', 'wikidata': 'https://www.wikidata.org/wiki/Q209369', 'display_name': 'Hodgkin lymphoma', 'level': 3, 'score': 0.1772703}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.06585908}, {'id': 'https://openalex.org/C151730666', 'wikidata': 'https://www.wikidata.org/wiki/Q7205', 'display_name': 'Paleontology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D006689', 'descriptor_name': 'Hodgkin Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000079963', 'descriptor_name': 'Brentuximab Vedotin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000079963', 'descriptor_name': 'Brentuximab Vedotin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D003606', 'descriptor_name': 'Dacarbazine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006689', 'descriptor_name': 'Hodgkin Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009367', 'descriptor_name': 'Neoplasm Staging', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012189', 'descriptor_name': 'Retrospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/37800293', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.71}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4387393286', 'https://openalex.org/W4380150045', 'https://openalex.org/W4231262991', 'https://openalex.org/W3016442292', 'https://openalex.org/W2991931587', 'https://openalex.org/W2970608623', 'https://openalex.org/W2335762340', 'https://openalex.org/W2291534125', 'https://openalex.org/W2130595908', 'https://openalex.org/W2068354603'], 'abstract_inverted_index': {'The': [0, 77, 82, 132], 'JSH': [1], 'Practical': [2], 'Guidelines': [3], 'for': [4, 21], 'Hematological': [5], 'Malignancies,': [6], '2018': [7], 'expanded': [8], 'edition,': [9], 'newly': [10, 49], 'adopted': [11], 'brentuximab': [12], 'vedotin,': [13], 'doxorubicin,': [14, 42], 'vinblastine,': [15, 44], 'dacarbazine(A+AVD)protocol': [16], 'as': [17], 'a': [18], 'standard': [19], 'treatment': [20], 'advanced-stage': [22, 75], 'classical': [23], 'Hodgkin': [24], 'lymphoma(CHL).': [25], 'Therefore,': [26], 'this': [27], 'retrospective': [28], 'analysis': [29], 'compared': [30], '15': [31], 'patients': [32, 39, 47, 102], 'who': [33, 40], 'received': [34, 41, 54], 'A+AVD': [35, 72, 89, 152], 'therapy': [36, 56], 'with': [37, 51, 103], '21': [38], 'bleomycin,': [43], 'dacarbazine(ABVD)therapy.': [45], 'All': [46, 66], 'were': [48, 157], 'diagnosed': [50], 'CHL': [52, 109], 'and': [53, 60, 142, 153], 'induction': [55], 'between': [57], 'April': [58], '2015': [59], 'June': [61], '2022': [62], 'in': [63, 121], 'our': [64], 'hospital.': [65], 'except': [67], '1': [68], 'patient': [69], 'of': [70, 87, 95], 'the': [71, 88, 96, 122, 129, 143, 151, 154], 'group': [73, 90, 98], 'had': [74], 'CHL.': [76], 'median': [78], 'age': [79], 'was': [80, 91, 117], '63(23-85)years.': [81], 'estimated': [83, 144], '2-year': [84, 145], 'overall': [85, 133], 'survival': [86], 'better': [92], 'than': [93], 'that': [94], 'ABVD': [97, 155], 'which': [99], 'included': [100], '6': [101], 'clinical': [104], 'stage': [105], 'Ⅲ': [106], 'or': [107], 'higher': [108], '(100%': [110], 'vs': [111, 126, 139, 148], '66.7%,': [112, 149], 'p=0.047).': [113], 'In': [114], 'contrast,': [115], 'there': [116], 'no': [118], 'significant': [119], 'difference': [120], 'complete': [123], 'response': [124, 134], 'rate(53.8%': [125], '100%,': [127, 140], 'p=0.109)between': [128], '2': [130], 'groups.': [131], 'rate': [135], 'after': [136], 'first-line': [137], 'treatment(69.2%': [138], 'p=0.255),': [141], 'progression-free': [146], 'survival(70.1%': [147], 'p=0.321)between': [150], 'groups': [156], 'similar.': [158]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4387393286', 'counts_by_year': [], 'updated_date': '2024-12-15T16:35:12.670650', 'created_date': '2023-10-07'}